Your account is not claimed yet. You can sign up with ORCID to claim your account.

Iman Azimi

ResearcherID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 13

Top Venues

Journal of cellular physiology

Pharmaceuticals (Basel, Switzerland)

Biomedicines

Cellular and molecular life sciences : CMLS

University of Tasmania

University of New South Wales (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Tasmania Jan 2o 2018

Australia

Lecturer and Research Group Head

Education History

University of New South Wales

Australia

PHD

Publications

Ahmed Maklad, Mohammed Sedeeq, Richard Wilson, John A Heath, Nuri Gueven, Iman Azimi
LIN28 expression and function in medulloblastoma. Journal of cellular physiology 238 (3) (2023)
Ahmed Maklad, Mohammed Sedeeq, Richard Wilson, John A Heath, Nuri Gueven, Iman Azimi
LIN28 expression and function in medulloblastoma. Journal of cellular physiology (2023)
Ahmed Maklad, Mohammed Sedeeq, Richard Wilson, John A Heath, Nuri Gueven, Iman Azimi
LIN28 expression and function in medulloblastoma. Journal of cellular physiology 238 (3) (2023)
Ahmed Maklad, Mohammed Sedeeq, Richard Wilson, John A Heath, Nuri Gueven, Iman Azimi
LIN28 expression and function in medulloblastoma. Journal of cellular physiology 238 (3) (2023)
Mohammed Sedeeq, Ahmed Maklad, Taush Dutta, Zikai Feng, Richard Wilson, Nuri Gueven, Iman Azimi
T-Type Calcium Channel Inhibitors Induce Apoptosis in Medulloblastoma Cells Associated with Altered Metabolic Activity. Molecular neurobiology 59 (5) (2022)
Ahmed Maklad, Mohammed Sedeeq, Michael J G Milevskiy, Iman Azimi
Calcium Signalling in Medulloblastoma: An In Silico Analysis of the Expression of Calcium Regulating Genes in Patient Samples. Genes 12 (9) (2021)
Mohammed Sedeeq, Ahmed Maklad, Nuri Guven, Iman Azimi
Development of a High-throughput Agar Colony Formation Assay to Identify Drug Candidates against Medulloblastoma. Pharmaceuticals (Basel, Switzerland) 13 (11) (2020)
Reza Mohammadinejad, Alessio Biagioni, Ganesan Arunkumar, Rebecca Shapiro, Kun-Che Chang, Mohammed Sedeeq, Aftab Taiyab, Mohammad Hashemabadi, Abbas Pardakhty, Ali Mandegary, Jean-Paul Thiery, Amir Reza Aref, Iman Azimi
EMT signaling: potential contribution of CRISPR/Cas gene editing. Cellular and molecular life sciences : CMLS 77 (14) (2020)
Rohit Gundamaraju, Wenying Lu, Iman Azimi, Rajaraman Eri, Sukhwinder Singh Sohal
Endogenous Anti-Cancer Candidates in GPCR, ER Stress, and EMT. Biomedicines 8 (10) (2020)
Iman Azimi, Mélanie Robitaille, Kaela Armitage, Choon Leng So, Michael J G Milevskiy, Korinne Northwood, Huai Fang Lim, Erik W Thompson, Sarah J Roberts-Thomson, Gregory R Monteith
Activation of the Ion Channel TRPV4 Induces Epithelial to Mesenchymal Transition in Breast Cancer Cells. International journal of molecular sciences 21 (24) (2020)
Zikai Feng, Mohammed Sedeeq, Abraham Daniel, Monika Corban, Krystel L Woolley, Ryan Condie, Iman Azimi, Jason A Smith, Nuri Guven
Comparative In Vitro Toxicology of Novel Cytoprotective Short-Chain Naphthoquinones. Pharmaceuticals (Basel, Switzerland) 13 (8) (2020)
Iman Azimi, Michael J G Milevskiy, Silke B Chalmers, Kunsala T D S Yapa, Mélanie Robitaille, Christopher Henry, Gregory J Baillie, Erik W Thompson, Sarah J Roberts-Thomson, Gregory R Monteith
ORAI1 and ORAI3 in Breast Cancer Molecular Subtypes and the Identification of ORAI3 as a Hypoxia Sensitive Gene and a Regulator of Hypoxia Responses. Cancers 11 (2) (2019)
Iman Azimi, Michael J G Milevskiy, Elke Kaemmerer, Dane Turner, Kunsala T D S Yapa, Melissa A Brown, Erik W Thompson, Sarah J Roberts-Thomson, Gregory R Monteith
TRPC1 is a differential regulator of hypoxia-mediated events and Akt signalling in PTEN-deficient breast cancer cells. Journal of cell science 130 (14) (2017)

Iman Azimi.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Iman Azimi